GlassScriptPhysician profile
Andrew A Avery
NPI 1255587945
$5,076.83
in general payments reported to CMS, 2019-2025
32 companies · $905 in 2025
The $905 reported for 2025 was more than what 92% of Sports Medicine (Internal Medicine) providers received nationally (typical 2025 total: $99.49).
See the full distribution for Sports Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $746 · 2020: $177 · 2021: $468 · 2022: $557 · 2023: $1,454 · 2024: $770 · 2025: $905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,128.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $689.99 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $648.37 | 2021-2024 | |
| Glaxosmithkline, LLC. | $428.56 | 2022-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Teva Pharmaceuticals USA, INC. | $382.56 | 2019-2022 | |
| Abbott Laboratories | $300.39 | 2021-2023 | Freestyle Libre 2 |
| Lilly USA, LLC | $278.83 | 2019-2025 | Mounjaro, Jardiance |
| Pfizer INC. | $234.37 | 2019-2023 | |
| Otsuka America Pharmaceutical, INC. | $215.93 | 2022-2024 | Rexulti |
| Boston Scientific Corporation | $213.82 | 2022-2023 | Watchman Access System |
| Alnylam Pharmaceuticals INC. | $182.18 | 2023 | Amvuttra |
| Amarin Pharma, INC. | $144.64 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $136.06 | 2023 | |
| Novartis Pharmaceuticals Corporation | $134.15 | 2019-2023 | |
| Aimmune Therapeutics, INC. | $125.00 | 2025 | Zenpep |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $115.15 | 2022-2025 | Caplyta |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $113.25 | 2025 | |
| Sanofi Pasteur INC. | $111.16 | 2023 | |
| Exact Sciences Corporation | $109.54 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $93.79 | 2020-2021 | |
| Novo Nordisk INC | $90.75 | 2020-2021 | |
| Amgen INC. | $81.15 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $42.93 | 2020-2021 | |
| Dexcom, INC. | $26.54 | 2023 | Dexcom G6 Transmitter |
| Axsome Therapeutics, INC. | $25.43 | 2024 | Auvelity |
| Phathom Pharmaceuticals, INC. | $24.19 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $23.77 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
| Sequel Med Tech, LLC | $19.33 | 2025 | Twiist |
| Gilead Sciences, INC. | $18.94 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.08 | 2022 | |
| Shield Therapeutics INC | $17.84 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.91 | 2019 | |
| Allergan, INC. | $13.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Avery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.